{"Abstract": [0], "The": [1], "2010": [2], "and": [3, 14, 28, 62, 68, 81, 101], "2017": [4], "editions": [5], "of": [6, 16, 38, 47, 53, 64, 72], "the": [7, 44, 54, 69], "European": [8], "LeukemiaNet": [9], "(ELN)": [10], "recommendations": [11], "for": [12], "diagnosis": [13], "management": [15], "acute": [17], "myeloid": [18], "leukemia": [19], "(AML)": [20], "in": [21, 35, 59], "adults": [22], "are": [23], "widely": [24], "recognized": [25], "among": [26], "physicians": [27], "investigators.": [29], "There": [30], "have": [31, 86], "been": [32], "major": [33], "advances": [34, 85], "our": [36], "understanding": [37], "AML,": [39, 48], "including": [40], "new": [41, 73], "knowledge": [42], "about": [43], "molecular": [45], "pathogenesis": [46], "leading": [49], "to": [50], "an": [51], "update": [52, 89], "disease": [55], "classification,": [56, 97], "technological": [57], "progress": [58], "genomic": [60], "diagnostics": [61], "assessment": [63], "measurable": [65], "residual": [66], "disease,": [67], "successful": [70], "development": [71], "therapeutic": [74], "agents,": [75], "such": [76], "as": [77], "FLT3,": [78], "IDH1,": [79], "IDH2,": [80], "BCL2": [82], "inhibitors.": [83], "These": [84], "prompted": [87], "this": [88], "that": [90], "includes": [91], "a": [92], "revised": [93, 98], "ELN": [94], "genetic": [95], "risk": [96], "response": [99], "criteria,": [100], "treatment": [102], "recommendations.": [103]}